Key points are not available for this paper at this time.
Radiopharmaceutical therapies are gaining increasing prominence as they improve survival in patients with common diseases such as metastatic prostate cancer ( 1 1, 2 2). However, whereas sodium iodide (131I) therapy has been used for over 70 y in treating malignant and benign thyroid
Wahl et al. (Wed,) studied this question.